260
P. Wang et al. / Journal of Molecular Liquids 198 (2014) 259–262
ppm; 13C NMR (CDCl3, 125 MHz) δ: 24.7, 28.1, 108.4, 123.1, 123.4, 128.9,
137.1, 147.1 ppm; ESI-MS: m/z = 228 (M + 1)+.
1-(4-(tert-Butyl)phenyl)-1H-pyrrole (3j). 1H NMR (CDCl3, 500 MHz)
δ: 1.35 (s, 9H), 6.34 (t, J = 2.0 Hz, 2H), 7.07 (t, J = 2.0 Hz, 2H), 7.33
(d, J = 7.0 Hz, 2H), 7.44 (d, J = 7.0 Hz, 2H) ppm; 13C NMR (CDCl3,
125 MHz) δ: 31.4, 34.5, 110.1, 119.4, 120.3, 126.4, 138.4, 148.7 ppm;
ESI-MS: m/z = 200 (M + 1)+.
Scheme 1. Synthesis of N-substituted pyrroles via Clauson-Kaas reactions in DES.
1-(2-Fluorophenyl)-1H-pyrrole (3k). 1H NMR (CDCl3, 500 MHz) δ:
6.38 (t, J = 2.0 Hz, 2H), 7.06 (t, J = 2.0 Hz, 2H), 7.19–7.26 (mk, 3H), 7.41
(t, J = 8.0 Hz, 1H) ppm; 13C NMR (CDCl3, 125 MHz) δ: 110.1, 117.1 (d,
using CDCl3 as the solvent with TMS as internal standard. Mass spectra
were operated at a ThermoFinnigan LCQ Advantage instrument with an
ESI source (4.5 keV).
4
4
2JFC = 20.3 Hz), 121.4 (d, JFC = 3.5 Hz), 124.8 (d, JFC = 3.8 Hz),
125.0, 127.2 (d, 3JFC = 7.9 Hz), 129.1 (d, 3JFC = 10.4 Hz), 155.1 (d, 1JFC
=
247.8 Hz) ppm; ESI-MS: m/z = 162 (M + 1)+.
2.2. Typical procedure for the preparation of N-substituted pyrroles
1-(4-Fluorophenyl)-1H-pyrrole (3l). 1H NMR (CDCl3, 500 MHz) δ:
6.35 (t, J = 2.0 Hz, 2H), 7.02 (t, J = 2.0 Hz, 2H), 7.12 (t, J = 8.5 Hz,
2H), 7.35 (d, J = 8.5 Hz, 1H), 7.36 (d, J = 8.5 Hz, 1H) ppm; 13C NMR
(CDCl3, 125 MHz) δ: 110.5, 116.3 (d, 2JFC = 22.6 Hz), 119.6, 122.3 (d,
3JFC = 8.1 Hz), 137.2, 160.7 (d, 1JFC = 243.2 Hz) ppm; ESI-MS: m/z =
162 (M + 1)+.
Amine (1 mmol), 2,5-dimethoxytetrahydrofuran (1.1 mmol)
and L-(+)-tartaric acid–choline chloride based DES (1.5 g) were
added to a 50 mL round bottom flask and the reaction mixture
was stirred at 90 °C. The progress of the reaction was monitored
by TLC. After completion of the reaction, the mixture was cooled
to room temperature and the product was extracted with ethyl acetate.
After the evaporation of the solvent, the residue was purified by column
chromatography on silica gel to afford the pure product. The DES was
dried under vacuum and reused for the next cycle.
1-(3-Chlorophenyl)-1H-pyrrole (3m). 1H NMR (CDCl3, 500 MHz) δ:
6.30 (t, J = 2.0 Hz, 2H), 6.99 (t, J = 2.0 Hz, 2H), 7.12–7.20 (m, 2H),
7.25 (dd, J = 8.5, 2.0 Hz, 1H), 7.32 (d, J = 2.0 Hz, 1H) ppm; 13C NMR
(CDCl3, 125 MHz) δ: 141.5, 135.0, 130.4, 125.3, 120.4, 119.0, 118.1,
110.8 ppm; ESI-MS: m/z = 179 (M + 1)+.
1-(4-Chlorophenyl)-1H-pyrrole (3n). 1H NMR (CDCl3, 500 MHz) δ:
6.36 (t, J = 2.0 Hz, 2H), 7.05 (t, J = 2.0 Hz, 2H), 7.33 (d, J = 8.5 Hz,
2H), 7.39 (d, J = 8.5 Hz, 1H) ppm; 13C NMR (CDCl3, 125 MHz) δ:
110.9, 119.3, 121.6, 129.7, 131.1, 139.4 ppm; ESI-MS: m/z = 179
2.3. Spectra data of the products
1-Phenyl-1H-pyrrole (3a). 1H NMR (CDCl3, 500 MHz) δ: 6.36 (t, J =
2.0 Hz, 2H), 7.10 (t, J = 2.0 Hz, 2H), 7.24–7.26 (m, 1H), 7.40–7.45 (m,
4H) ppm; 13C NMR (CDCl3, 125 MHz) δ: 110.5, 119.4, 120.6, 125.7,
129.6, 140.9 ppm; ESI-MS: m/z = 144 (M + 1)+.
(M + 1)+
.
1-(2-Bromophenyl)-1H-pyrrole (3o). 1H NMR (CDCl3, 500 MHz) δ:
6.34 (t, J = 2.0 Hz, 2H), 6.99 (t, J = 2.0 Hz, 2H), 7.24 (td, J = 8.5, 1.5 Hz,
1H), 7.33 (dd, J = 8.5, 1.5 Hz, 1H), 7.39 (td, J = 8.5, 1.5 Hz, 1H), 7.69 (dd,
J = 8.5, 1.5 Hz, 1H) ppm; 13C NMR (CDCl3, 125 MHz) δ: 109.2, 119.8,
3-(1H-Pyrrol-1-yl)phenol (3b). 1H NMR (CDCl3, 500 MHz) δ: 4.88
(brs, 1H), 6.34 (t, J = 2.0 Hz, 2H), 6.70 (dd, J = 8.0 Hz, 2.0 Hz, 1H),
6.89 (t, J = 2.0 Hz, 1H), 6.98 (dd, J = 8.0 Hz, 2.0 Hz, 1H), 7.07 (t, J =
2.0 Hz, 2H), 7.27 (t, J = 8.0 Hz, 1H) ppm; 13C NMR (CDCl3, 125 MHz)
δ: 107.9, 110.7, 127.8, 113.1, 119.5, 130.8, 142.2, 156.6 ppm; ESI-MS:
m/z = 160 (M + 1)+.
122.2, 128.1, 128.3, 133.7, 140.4 ppm; ESI-MS: m/z = 223 (M + 1)+
.
1-(3-Bromophenyl)-1H-pyrrole (3p). 1H NMR (CDCl3, 500 MHz) δ:
6.35 (s, 2H), 7.06 (s, 2H), 7.28 (t, J = 7.5 Hz, 1H), 7.33 (d, J = 7.5 Hz,
1H), 7.36 (d, J = 7.5 Hz, 1H), 7.55 (s, 1H) ppm; 13C NMR (CDCl3,
125 MHz) δ: 111.1, 118.9, 119.3, 123.2, 123.5, 128.6, 130.9,
141.9 ppm; ESI-MS: m/z = 223 (M + 1)+.
1-(2-Methoxyphenyl)-1H-pyrrole (3c). 1H NMR (CDCl3, 500 MHz) δ:
3.85 (s, 3H), 6.34 (s, 2H), 7.01–7.05 (m, 4H), 7.28–7.32 (m, 2H) ppm;
13C NMR (CDCl3, 125 MHz) δ: 55.7, 108.7, 112.2, 120.8, 121.9, 125.6,
127.4, 130.2, 152.6 ppm; ESI-MS: m/z = 174 (M + 1)+.
1-(4-Bromophenyl)-1H-pyrrole (3q). 1H NMR (CDCl3, 500 MHz) δ:
6.40 (s, 2H), 7.14 (s, 2H), 7.50 (d, J = 9.0 Hz, 2H), 7.69 (d, J = 9.0 Hz,
2H) ppm; 13C NMR (CDCl3, 125 MHz) δ: 111.6, 119.1, 119.9, 126.9,
143.2 ppm; ESI-MS: m/z = 223 (M + 1)+.
1-(4-Methoxyphenyl)-1H-pyrrole (3d). 1H NMR (CDCl3, 500 MHz)
δ: 3.84 (s, 3H), 6.32 (t, J = 2.0 Hz, 2H), 6.95 (d, J = 9.0 Hz, 2H), 7.00
(t, J = 2.0 Hz, 2H), 7.31 (d, J = 9.0 Hz, 2H) ppm; 13C NMR (CDCl3,
125 MHz) δ: 55.6, 109.8, 114.6, 119.7, 122.2, 134.5, 157.7 ppm;
1-(4-Iodophenyl)-1H-pyrrole (3r). IR (KBr): 3130, 1587, 1496,
1409, 1330, 1247, 1126, 1078, 1001, 920, 815, 729 cm−1 1H NMR
;
ESI-MS: m/z = 174 (M + 1)+
.
(CDCl3, 500 MHz) δ: 6.36 (t, J = 2.0 Hz, 2H), 7.05 (t, J = 2.0 Hz, 2H),
7.15 (d, J = 9.0 Hz, 2H), 7.73 (d, J = 9.0 Hz, 2H) ppm; 13C NMR
(CDCl3, 125 MHz) δ: 89.4, 111.0, 119.1, 122.2, 138.6, 140.4 ppm; ESI-
MS: m/z = 270 (M + 1)+.
1-(2-Tolyl)-1H-pyrrole (3e). 1H NMR (CDCl3, 500 MHz) δ: 2.25 (s,
3H), 6.35 (t, J = 2.0 Hz, 2H), 6.83 (t, J = 2.0 Hz, 2H), 7.27–7.32 (m,
4H) ppm; 13C NMR (CDCl3, 125 MHz) δ: 17.7, 108.6, 121.9, 126.4, 126.5,
127.4, 130.9, 133.6, 140.5 ppm; ESI-MS: m/z = 158 (M + 1)+.
1-(4-Tolyl)-1H-pyrrole (3f). 1H NMR (CDCl3, 500 MHz) δ: 2.38 (s, 3H),
6.34 (t, J = 2.0 Hz, 2H), 7.06 (t, J = 2.0 Hz, 2H), 7.22 (d, J = 8.0 Hz, 2H),
7.29 (d, J = 8.0 Hz, 2H) ppm; 13C NMR (CDCl3, 125 MHz) δ: 20.9, 110.2,
119.5, 120.6, 130.1, 135.4, 138.6 ppm; ESI-MS: m/z = 158 (M + 1)+.
1-(2,5-Dimethylphenyl)-1H-pyrrole (3g). 1H NMR (CDCl3, 500 MHz)
δ: 2.34 (s, 3H), 2.51 (s, 3H), 6.49 (t, J = 2.0 Hz, 2H), 6.62 (t, J = 2.0 Hz,
2H), 7.25 (s, 2H), 7.33 (s, 1H) ppm; 13C NMR (CDCl3, 125 MHz) δ:
17.6, 20.9, 108.8, 122.1, 127.4, 128.3, 130.6, 131.0, 136.4, 140.6 ppm;
ESI-MS: m/z = 172 (M + 1)+.
1-(3-Nitrophenyl)-1H-pyrrole (3s). 1H NMR (CDCl3, 500 MHz) δ:
6.38 (t, J = 2.0 Hz, 2H), 6.82 (t, J = 2.0 Hz, 2H), 7.46-7.49 (m, 2H),
7.65 (t, J = 8.5 Hz, 1H), 7.85 (d, J = 8.6 Hz, 1H) ppm; 13C NMR
(CDCl3, 125 MHz) δ: 145.0, 133.9, 133.0, 127.6, 127.5, 124.7, 121.1,
110.8 ppm; ESI-MS: m/z = 189 (M + 1)+.
1-(4-Nitrophenyl)-1H-pyrrole (3t). 1H NMR (CDCl3, 500 MHz) δ: 6.43
(t, J = 2.0 Hz, 2H), 7.18 (t, J = 2.0 Hz, 2H), 7.52 (d, J = 9.0 Hz, 2H), 8.31
(d, J = 9.0 Hz, 2H) ppm; 13C NMR (CDCl3, 125 MHz) δ: 112.6, 119.1,
119.4, 125.6, 144.7, 145.2 ppm; ESI-MS: m/z = 189 (M + 1)+.
1-(4-(1H-pyrrol-1-yl)phenyl)ethanone (3u). 1H NMR (CDCl3, 500
MHz) δ: 2.62 (s, 3H), 6.39 (t, J = 2.0 Hz, 2H), 7.17 (t, J = 2.0 Hz, 2H),
7.47 (d, J = 8.5 Hz, 2H), 8.03 (d, J = 8.5 Hz, 2H) ppm; 13C NMR
(CDCl3, 125 MHz) δ: 26.6, 111.7, 119.0, 119.3, 130.2, 133.9, 144.0,
196.8 ppm; ESI-MS: m/z = 186 (M + 1)+.
1-(2,6-Dimethylphenyl)-1H-pyrrole (3h). 1H NMR (CDCl3, 500 MHz)
δ: 2.05 (s, 6H), 6.33 (s, 2H), 6.62 (s, 2H), 7.13 (d, J = 7.5 Hz, 2H), 7.21
(t, J = 7.5 Hz, 1H) ppm; 13C NMR (CDCl3, 125 MHz) δ: 17.4, 108.6,
121.4, 128.0, 136.3, 140.0 ppm; ESI-MS: m/z = 172 (M + 1)+.
1-(2,6-Diisopropylphenyl)-1H-pyrrole (3i). 1H NMR (CDCl3, 500 MHz)
δ: 1.14 (d, J = 7.0 Hz, 12H), 2.39-2.48 (m, 1H), 6.32 (t, J = 2.0 Hz, 2H),
6.64 (t, J = 2.0 Hz, 2H), 7.22 (d, J = 7.5 Hz, 2H), 7.39 (t, J = 7.5 Hz, 1H)
1-(3-(Trifluoromethyl)phenyl)-1H-pyrrole (3v). 1H NMR (CDCl3,
500 MHz) δ: 6.39 (t, J = 2.5 Hz, 2H), 7.11 (t, J = 2.0 Hz, 2H), 7.50
(d, J = 7.5 Hz, 1H), 7.53-7.58 (m, 2H), 7.63 (s, 1H) ppm; 13C NMR